Business Wire

CA-YUBICO

6.5.2024 15:01:34 CEST | Business Wire | Press release

Share
Yubico’s Key Product Innovations Empower Enterprise Security and Phishing-Resistant Passwordless Authentication at Scale

Today Yubico (NASDAQ: YUBICO), the leading provider of hardware authentication security keys, announced the upcoming release of YubiKey 5.7 firmware for the YubiKey 5 Series, Security Key Series and Security Key Series - Enterprise Edition. With a focus on enterprise needs, these updates reinforce Yubico’s commitment to providing secure, simple, and scalable authentication solutions. Security keys with firmware 5.7 will be available to purchase in late May 2024, offering enhanced features such as improved PIN complexity, enterprise attestation, and expanded passkey credentials storage. These updates empower organizations to adopt passwordless-first, modern authentication, fostering phishing-resistant users worldwide.

As part of Yubico’s goal of helping enterprises raise the bar for security with greater flexibility, the company also announced the availability of Yubico Authenticator 7 which will support the upcoming YubiKey 5.7 features.

“Organizations are continuing to face a surge in the variety and complexity of cyber threats at historical rates, often fueled by compromised employee login credentials, frequently resulting from attacks such as phishing. This trend is exacerbated by the rise in use of Artificial Intelligence (AI),” said Jeff Wallace, senior vice president of product at Yubico. “We’re excited to continue offering best-in-class solutions that protect organizations and accelerate their transition to passwordless with the latest enterprise-focused updates to the YubiKey. We’re confident that organizations are now better equipped than ever to enforce compliance requirements and elevate their security posture throughout their organization.”

YubiKey 5.7: Accelerating enterprises to passwordless

To help organizations tackle this challenge, Yubico’s key updates and enhancements to the YubiKey 5 Series and Security Key Series* include:

  • Enhanced PIN complexity across all YubiKey applications
    • Block simple patterns and common PINs at the hardware level to enable compliance with upcoming NIST requirements and corporate mandates. This includes FIDO2, PIV, and OpenPGP.
  • Enterprise attestation
    • Allow organizations to enforce the usage of YubiKeys that they purchased via custom programmed keys with enterprise attestation. Working in conjunction with identity providers, this capability can also facilitate the retrieval of unique identifiers during FIDO2 registration to streamline asset tracking and account recovery.
  • FIDO2 enhancements
    • Empower organizations to enforce compliance requirements and elevate security measures surrounding PIN usage. YubiKey 5.7 implements FIDO Client-to-Authenticator Protocol (CTAP) 2.1, embracing the latest FIDO2 protocol features such as Force PIN Change and Minimum PIN Length.
  • Expanded passkey and passwordless storage
    • Provide ample storage space to meet authentication needs while maintaining strong security standards. More storage for FIDO2 discoverable credentials (passkeys) and OATH one-time passwords will now accommodate up to 100 passkeys, 24 PIV certificates, 64 OATH seeds, and 2 OTP seeds at once for a total of 190 credentials.
  • Expansion and enhancement of public key algorithms for PIV applications
    • Align with DoD memo requirements and offer advanced key management functions, enhancing flexibility for organizations through support of larger RSA keys (RSA-3072 and RSA-4096), as well as Ed25519 and X25519 key types.
  • Migration to Yubico’s own cryptographic library
    • Yubico has developed a library in-house that performs the underlying cryptographic operations (decryption, signing, etc.) for RSA and ECC.

“The new features within 5.7 allow enterprises to streamline critical processes such as asset tracking and account recovery, while also enhancing flexibility,” said Wallace. “These updates empower enterprises with the latest authentication advancements and tools to build specific strategies for creating phishing-resistant users and mitigating phishing threats for employees, external identities, and customers.”

Capabilities in the new 5.7 YubiKeys also align with recent U.S. Government memo requirements on adopting phishing-resistant MFA and offer advanced key management functions. Compliance with upcoming NIST requirements and corporate mandates is also supported by enforcing the blocking of simple patterns and common PINs at the hardware level.

*Note: Smart Card/PIV capabilities, OATH and OTP credentials are not available on any Security Key Series thus these updates are not applicable. Enterprise attestation is available on the YubiKey 5 Series and Security Key Series - Enterprise Edition. See here for more details.

Yubico Authenticator 7: Hardware-backed authenticator app across desktop and mobile

Aligned with the 5.7 firmware release, significant updates within Yubico Authenticator 7 launched today in support of managing these new features. This new version enables use of the new public key algorithms for PIV, bringing more advanced management options and streamlines the interface for a better user experience when handling many credentials. Additionally, it adds localization with official support for French and Japanese, with additional community-provided translations. The app is now available for all major desktop platforms, as well as for Android. Enhanced features for iOS will be coming in the next version of the iOS application. It's the perfect companion to the new YubiKey 5.7, with its expanded credential storage.

The Yubico Authenticator delivers strong security by enabling users to store credentials on a YubiKey instead of a mobile phone, thereby significantly removing risks posed by remote attackers targeting software-based authenticator apps. By incorporating hardware-backed strong two-factor authentication in the YubiKey, credentials stays safe and the bar for security is raised while delivering the convenience of an authenticator app.

For more information on today’s innovation announcements from Yubico, visit here. To get the Yubico Authenticator 7 app, visit here.

About Yubico

Yubico (Nasdaq First North Growth Market Stockholm: YUBICO), the inventor of the YubiKey, offers the gold standard for phishing-resistant multi-factor authentication (MFA), stopping account takeovers in their tracks and making secure login easy and available for everyone. Since the company was founded in 2007, it has been a leader in setting global standards for secure access to computers, mobile devices, servers, browsers, and internet accounts. Yubico is a creator and core contributor to the FIDO2, WebAuthn, and FIDO Universal 2nd Factor (U2F) open authentication standards, and is a pioneer in delivering modern, hardware-based passkey authentication security at scale to customers in over 160 countries.

Yubico’s solutions enable passwordless logins using the most secure form of passkey technology. YubiKeys work out-of-the-box across hundreds of consumer and enterprise applications and services, delivering strong security with a fast and easy experience.

As part of its mission to make the internet more secure for everyone, Yubico donates YubiKeys to organizations helping at-risk individuals through the philanthropic initiative, Secure it Forward. The company is headquartered in Stockholm and Santa Clara, CA. For more information on Yubico, visit us at www.yubico.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240506185894/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release

Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break

Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye